UAB has launched the Pancreatobiliary Disease Center to address these problems. All patients with malignancies referred to the PDC will be assessed in a multidisciplinary fashion, receive genetic ...

The PDC also conducts data collection and outcomes research, so we are able to select the best therapeutic approach for each patient based on the accumulated data available, ensuring that we offer ...

BPDCN is an aggressive hematologic malignancy with a historically poor prognosisVisualDx is a clinical decision support system used by more than ...

The company’s core objective is to leverage its proprietary Phospholipid Drug Conjugate™ (PDC) delivery platform to develop the next-generation of cancer cell-targeting treatments, delivering ...

A replay of the corporate presentation will be available on the Events section of the company’s Investor Relations website.